Advances in Immunological Therapeutics

  • HMX
Advances in Immunological Therapeutics Course Illustration.
Register Now

Available Anytime

Start Today Register and begin immediately.

Group Enrollment Option Popular with companies and institutions for team-wide training.

Learn about innovative immunological therapies approved by the FDA from 2021 through 2023 for the treatment of a number of chronic diseases.

  • Online; Self-Paced

Enroll and gain access to course materials to complete at your own pace.

$495

Save and learn more with discounted multi‑course bundles or our all‑access HMX and HealthXcelerate Learning Pass.

Certificate

Earn a short course certificate of completion when you finish all coursework within 8 weeks.

3-4 Hours

Most people can expect to complete short courses in 3-4 hours.

On This Page

Overview

Over the past few decades, it has become increasingly clear that a weakened or overactive immune response underlies the development of many chronic conditions, ranging from autoimmune diseases to cancer. Advances in our understanding of our immune system has led to the development of therapies that modulate immune responses to treat various conditions with an immunological basis.  

In this HMX short course, you will learn from leading Harvard Medical School faculty about cutting-edge immunological therapeutics that have been recently approved by the FDA in 2023 for the treatment of a number of different chronic diseases. Learning how new therapies enhance or suppress our immune system is essential for anyone looking to develop or apply new immunomodulatory therapies to treat disease. 

Harvard HMX Logo Wide HMX Online Learning

Who Should Participate

Researchers in biomedicine and pharmacology; clinicians and other medical professionals; professionals in managerial roles in health care and the pharmaceutical or a related industry

About the Course

HMX short courses feature targeted lessons on the latest medical science topics and advancements. Stay up-to-date on essential knowledge in both artificial intelligence (AI) and immunology by exploring these specialized topics in a shorter format.

Who Should Participate

This course will benefit researchers in biomedicine and pharmacology who are keen to learn about the latest developments in immunological treatments with a strong emphasis on understanding the pathology of the diseases they are designed to treat; clinicians and other medical professionals seeking a firm understanding of the mechanisms of action of new immunological therapeutics; professionals in managerial roles in health care and the pharmaceutical industry who are interested in a well-structured overview of how different aspects of the immune system are being harnessed to develop drugs that treat inflammatory diseases and cancer.

Course Format

Most people can expect to spend 3-4 hours total on an HMX short course. In order to be considered for a short course certificate of completion, you must complete your coursework within eight weeks.

Additional Course Information

For information around payments and policies, please review our frequently asked questions.

  • Treating Skin Inflammation
  • Lymphocyte Depletion
  • Immune Checkpoint Blockade
  • Complement Inhibition
  • Reducing the Half-Life of IgG
  • Blocking Type I Interferons
  • Blocking Other Kinases

Earn a short course certificate of completion when you finish all coursework within 8 weeks.

Extend Your Learning and Save More

Whether you are building your medical science knowledge, preparing for advanced study, or expanding your understanding of the health care ecosystem, combining courses helps you connect concepts across disciplines while saving on enrollment.

Image
Bundle Icon

Enroll in Multiple Courses and Save

Combine up to five courses and unlock discounts up to 40%

You can bundle up to five HMX or HealthXcelerate courses. Bundle discounts apply to all courses selected. A bundle can consist of courses in the same upcoming enrollment period or the following enrollment period. 

Two-course bundle: 25% discount 
Three-course bundle: 30% discount 
Four-course bundle: 35% discount
Five-course bundle: 40% discount

View all bundle-eligible programs

Multi-course discounts will be changing on October 1, 2026. Register now and lock in these savings by bundling multiple courses.

Image
All Access Icon

HMX and HealthXcelerate Learning Pass

Unlock both HMX and HealthXcelerate courses all year long with one simple enrollment fee

With the HMX and HealthXcelerate Learning Pass, a $4,950 investment unlocks one year of unlimited enrollment to Harvard Medical School's portfolio of HMX and HealthXcelerate online courses, empowering you to advance your knowledge of health care and medical science in the areas that matter most to your goals. Start Learning

Image
Group icon

Learn as a Team with Group Enrollments

Expand your impact and savings when you learn together

HMX and HealthXcelerate courses are ideal for organizations looking to train teams or larger groups. Group pricing is available, making it a cost-effective investment in team development.

Contact Our Team

Frequently Asked Questions

Follow the link below for more information around payment and policies.

Additional FAQs

Advances in Immunological Therapeutics provides an overview of therapies approved by the FDA from 2021 through 2023 for the treatment of a number of chronic diseases. You’ll learn how these interventions work, where they’re used, and how they are reshaping treatment across oncology, autoimmune disease, and other conditions.

Course highlights for Advances in Immunological Therapeutics include treating skin inflammation, lymphocyte depletion, immune checkpoint blockade, complement inhibition, reducing the half-life of IgG, blocking type I interferons, and blocking other kinases.

Advances in Immunological Therapeutics is ideal for clinicians, trainees, researchers, and industry professionals who want to understand how immune-based therapies are designed, evaluated, and integrated into patient care.

Advances in Immunological Therapeutics is right for you if you want a medically oriented introduction to immune-based interventions that connects immunology directly to real-world treatment decisions, particularly if you care for patients on immunotherapies or collaborate with clinical, translational, or biopharma teams in this area.

Advances in Immunological Therapeutics is worth the investment because it offers a practical understanding of major immunotherapeutic classes, their clinical uses, and safety considerations, enabling better communication with colleagues and more informed engagement with new data and products, supported by a Certificate of Completion from Harvard Medical School.

Becoming an expert in immunological therapeutics usually involves advanced clinical training (for example, in internal medicine, oncology, or rheumatology) or a PhD/graduate training in immunology, plus research or clinical trial experience. Advances in Immunological Therapeutics will not replace that training, but it provides a clinically relevant foundation that can help you succeed in advanced programs or in roles across clinical development, medical affairs, and patient care.

Advances in Immunological Therapeutics is an online, self-paced course. Most people can expect to spend 3-4 hours total on an HMX short course. To be considered for a short course certificate of completion, you must complete your coursework within eight weeks.

By completing all course material for Advances in Immunological Therapeutics within 8 weeks, you can earn a Short Course Certificate of Completion from Harvard Medical School.

You can include Advances in Immunological Therapeutics in a bundle of up to five courses. Bundle discounts apply to all selected HMX and HealthXcelerate courses and can span the same or next enrollment period: 

Two-course bundle: 25% discount 
Three-course bundle: 30% discount 
Four-course bundle: 35% discount
Five-course bundle: 40% discount

Or gain unlimited enrollment in over 40 courses with the HMX and HealthXcelerate Learning Pass for a one-time $4,950 investment. 

Group Enrollments

HMX courses are ideal for organizations looking to train teams or larger groups. Group pricing is available, making it a cost-effective investment in team development.

Contact Our Team

Faculty

HMX courses are led by Harvard Medical School faculty, working in collaboration with a multi-disciplinary team of experts in biomedical visualization, assessment, and the science of learning to create a unique learning experience that will stay with you.
Carlos Donado Headshot.

Carlos Donado

PhD

  • Instructor in Medicine, Harvard Medical School / Immunologist, Brigham and Women’s Hospital
  • Immunology Curriculum Fellow, HMX
Shiv Pillai Headshot.

Shiv Pillai

MD, PhD

  • Professor of Medicine and Health Sciences and Technology, Harvard Medical School
Andrew Lichtman headshot.

Andrew Lichtman

MD, PhD

  • Professor of Pathology, Harvard Medical School
  • Pathologist, Brigham and Women's Hospital

Explore Related Courses

Immune Tolerance

Learn about immune tolerance and how it can be harnessed to treat various conditions.

  • HMX Online Learning
  • Online; Self-Paced
  • Start Today
  • Group Enrollment Option

Dates: Available Anytime

For: Medical professionals; biomedical researchers; professionals in health care-related fields

Allergy and Asthma: Immunological Principles and Therapeutics

Learn about the immunological principles of allergic diseases, including asthma, food allergies, and atopic dermatitis, and explore how these conditions can be treated and prevented.

  • HMX Online Learning
  • Online; Self-Paced
  • Start Today
  • Group Enrollment Option

Dates: Available Anytime

For: Medical professionals; biomedical researchers; professionals in health care-related fields

Immunology Fundamentals

Get an in-depth look at how the body fights disease – and how new therapies can help.

  • HMX Online Learning
  • Online; Instructor-Paced
  • Group Enrollment Option

Dates: -

For: Pre-med students; Current medical students; Health care professionals working in R&D, product management and strategy, sales, and marketing

Immuno-oncology

Learn how the immune system is being harnessed to improve cancer treatment.

  • HMX Online Learning
  • Online; Instructor-Paced
  • Group Enrollment Option

Dates: -

For: Scientists in immunology or cancer-related research; clinicians or other medical professionals; health care industry and research professionals

Novel Therapies for Chronic Inflammation, Autoimmunity, and Allergy

Learn how the immune system is being harnessed to treat diseases caused by inflammatory immune responses.

  • HMX Online Learning
  • Online; Instructor-Paced
  • Group Enrollment Option

Dates: -

For: Medical professionals; biomedical researchers; professionals in health care-related fields

Vaccines and Viral Immunology

Learn how the immune system is being harnessed to create vaccines that protect against infections by disease-causing viruses.

  • HMX Online Learning
  • Online; Instructor-Paced
  • Group Enrollment Option

Dates: -

For: Medical professionals; researchers in immunology or adjacent fields; professionals in the biotechnology or pharmaceutical industries

Request Information

Interested in learning more about this program? Sign up for details.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

In order to comply with applicable U.S. export control and sanctions regulations, Harvard Medical School prohibits access to and use of Harvard Medical School educational offerings, programs and resources to individuals from certain sanctioned regions or who are otherwise subject to U.S. government sanctions, unless appropriate authorization is in place.

Program Topics